The tumor suppressor, Merlin from 22q12 is inactivated in nearly two-thirds of meningiomas and is a member of the protein 4.1 superfamily of cytoskeleton linker proteins that includes erzin, radixin, and moesin (ERM) (14, 66, 67). This evidence concerns the gene NF2 and meningioma.